Literature DB >> 16009686

Dynamics of mucosal permeability and inflammation in collagenous colitis before, during, and after loop ileostomy.

A Münch1, J D Söderholm, C Wallon, A Ost, G Olaison, M Ström.   

Abstract

Collagenous colitis has become a more frequent diagnosis but the aetiology of this disease is still unknown. We describe a female patient with intractable collagenous colitis who was treated with a temporary loop ileostomy. She was followed clinically, histopathologically, and functionally by measuring mucosal permeability before surgery, after ileostomy, and after bowel reconstruction. In our case report, active collagenous colitis was combined with increased transcellular and paracellular mucosal permeability. Diversion of the faecal stream decreased inflammation of the mucosa and normalised epithelial degeneration and mucosal permeability. After restoration of bowel continuity, mucosal permeability was altered prior to the appearance of a collagenous layer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009686      PMCID: PMC1774864          DOI: 10.1136/gut.2004.058750

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

Review 1.  Intestinal permeation and gastrointestinal disease.

Authors:  Mark T DeMeo; Ece A Mutlu; Ali Keshavarzian; Mary C Tobin
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

2.  Role of bile acids and bile acid binding agents in patients with collagenous colitis.

Authors:  K A Ung; R Gillberg; A Kilander; H Abrahamsson
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

3.  Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.

Authors:  R T Jenkins; D B Jones; R L Goodacre; S M Collins; G Coates; R H Hunt; J Bienenstock
Journal:  Am J Gastroenterol       Date:  1987-11       Impact factor: 10.864

4.  Long-term course in collagenous colitis and the impact of bile acid malabsorption and bile acid sequestrants on histopathology and clinical features.

Authors:  K A Ung; A Kilander; O Nilsson; H Abrahamsson
Journal:  Scand J Gastroenterol       Date:  2001-06       Impact factor: 2.423

5.  Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease.

Authors:  J D Söderholm; G Olaison; K H Peterson; L E Franzén; T Lindmark; M Wirén; C Tagesson; R Sjödahl
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

Review 6.  Interventions for treating collagenous colitis.

Authors:  N Chande; J W McDonald; J K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2003

7.  Mechanisms of diarrhea in collagenous colitis.

Authors:  Natalie Bürgel; Christian Bojarski; Joachim Mankertz; Martin Zeitz; Michael Fromm; Jörg-Dieter Schulzke
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

8.  Role of tight-junctional pathways in bile salt-induced increases in colonic permeability.

Authors:  R W Freel; M Hatch; D L Earnest; A M Goldner
Journal:  Am J Physiol       Date:  1983-12

Review 9.  Collagenous, microscopic and lymphocytic colitis. An evolving concept.

Authors:  W V Bogomoletz
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.

Authors:  J D Söderholm; C Streutker; P-C Yang; C Paterson; P K Singh; D M McKay; P M Sherman; K Croitoru; M H Perdue
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

View more
  20 in total

1.  Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.

Authors:  Archana S Rao; Michael Camilleri; Deborah J Eckert; Irene Busciglio; Duane D Burton; Michael Ryks; Banny S Wong; Jesse Lamsam; Ravinder Singh; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

Review 2.  Microscopic colitis: an approach to treatment.

Authors:  Nilesh Chande
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

3.  Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis.

Authors:  Amy J Thorsen
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 4.  Microscopic colitis: a review for the surgical endoscopist.

Authors:  Indraneel Datta; Savtaj S Brar; Christopher N Andrews; Marc Dupre; Chad G Ball; W Donald Buie; Paul L Beck
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

5.  Microscopic Colitis: A Review of Collagenous and Lymphocytic Colitis.

Authors:  Karen Boland; Geoffrey C Nguyen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-11

6.  Mucosa-associated bacteria in two middle-aged women diagnosed with collagenous colitis.

Authors:  Rita J Gustafsson; Bodil Ohlsson; Cecilia Benoni; Bengt Jeppsson; Crister Olsson
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

7.  Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Authors:  Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

Review 8.  Diagnosis and management of microscopic colitis.

Authors:  Curt Tysk; Johan Bohr; Nils Nyhlin; Anna Wickbom; Sune Eriksson
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

Review 9.  Microscopic colitis.

Authors:  Kristin E Burke; Mauro D'Amato; Siew C Ng; Darrell S Pardi; Jonas F Ludvigsson; Hamed Khalili
Journal:  Nat Rev Dis Primers       Date:  2021-06-10       Impact factor: 52.329

Review 10.  Microscopic colitis: A review of etiology, treatment and refractory disease.

Authors:  Tina Park; David Cave; Christopher Marshall
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.